Esmo 2024 Abstract Submission Date. Esmo targeted anticancer therapies congress 2024. There are already some data here on bnt327, from a chinese 1/2 trial presented at sabcs.
A few weeks prior to each conference, our experts carefully examine all abstracts to identify presentations and posters most likely to relay new data with the potential to impact the. The esmo 2024 conference will unveil significant new findings in gastrointestinal cancers, highlighting advancements in the treatment of cervical, endometrial, and ovarian.